业务
货币单位:人民币
2024/FY
名称营收比例
Research and development, manufacturing and trading of Chinese pharmaceutical products37.78亿100.00%
地区
货币单位:人民币
2024/FY
名称营收比例
The People’s Republic of China (PRC) including Hong Kong37.78亿100.00%